{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:19:01Z","timestamp":1788985141809,"version":"build-2803163510"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T00:00:00Z","timestamp":1651276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ebiom.2022.104062","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T19:08:09Z","timestamp":1652814489000},"page":"104062","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine"],"prefix":"10.1016","volume":"80","author":[{"given":"S\u00e9verin","family":"Col\u00e9on","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Wiedemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Sur\u00e9naud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6925-0225","authenticated-orcid":false,"given":"Christine","family":"Lacabaratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Hue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Prague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minerva","family":"Cervantes-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5224-3889","authenticated-orcid":false,"given":"Jerome","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Sansoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Pierini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Bardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Fabregue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Sharkaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Hoest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Dupaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"El Hajj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille","family":"Centlivre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade","family":"Ghosn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolphe","family":"Thi\u00e9baut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Cardinaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Malissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Zurawski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Zarubica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra M.","family":"Zurawski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Godot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"L\u00e9vy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2022.104062_bib0001","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa2028436","article-title":"Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults","volume":"383","author":"Anderson","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2022.104062_bib0002","doi-asserted-by":"crossref","DOI":"10.2139\/ssrn.3820576","article-title":"T-cell and antibody responses to first BNT162b2 vaccine dose in previously SARS-CoV-2-infected and infection-naive UK healthcare workers: a multicentre, prospective, observational cohort study","author":"Angyal","year":"2021","journal-title":"SSRN J"},{"key":"10.1016\/j.ebiom.2022.104062_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109570","article-title":"Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals","volume":"36","author":"Lozano-Ojalvo","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.ebiom.2022.104062_bib0004","doi-asserted-by":"crossref","unstructured":"Kalimuddin S, Tham CYL, Qui M, et al. Early T cell and binding antibody responses are associated with COVID-19 RNA vaccine efficacy onset. Med (N Y). 2021;2(6):682\u2013688.e4","DOI":"10.1016\/j.medj.2021.04.003"},{"key":"10.1016\/j.ebiom.2022.104062_bib0005","doi-asserted-by":"crossref","DOI":"10.1172\/JCI149150","article-title":"First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19","volume":"131","author":"Mazzoni","year":"2021","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.ebiom.2022.104062_bib0006","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.immuni.2021.08.001","article-title":"Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immune responses to SARS-CoV-2 mRNA vaccination","volume":"54","author":"Painter","year":"2021","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.ebiom.2022.104062_bib0007","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/annrheumdis-2021-220626","article-title":"Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression","volume":"80","author":"Prendecki","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ebiom.2022.104062_bib0008","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","article-title":"COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses","volume":"586","author":"Sahin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2022.104062_bib0009","article-title":"Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals","volume":"2","author":"Tarke","year":"2021","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.ebiom.2022.104062_bib0010","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41586-020-03041-6","article-title":"Correlates of protection against SARS-CoV-2 in rhesus macaques","volume":"590","author":"McMahan","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2022.104062_bib0011","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2021.01.007","article-title":"Adaptive immunity to SARS-CoV-2 and COVID-19","volume":"184","author":"Sette","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2022.104062_bib0012","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2021.26.16.2100348","article-title":"Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU\/EEA countries, weeks 38\/2020 to 10\/2021","volume":"26","author":"Funk","year":"2021","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.ebiom.2022.104062_bib0013","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41591-021-01255-3","article-title":"Sixteen novel lineages of SARS-CoV-2 in South Africa","volume":"27","author":"Tegally","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2022.104062_bib0014","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1128\/JVI.00119-21","article-title":"Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil","volume":"95","author":"Voloch","year":"2021","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2022.104062_bib0015","article-title":"Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India","author":"Cherian","year":"2021","journal-title":"Mol Biol"},{"key":"10.1016\/j.ebiom.2022.104062_bib0016","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1016\/S0140-6736(21)02758-6","article-title":"Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic","volume":"398","author":"Karim","year":"2021","journal-title":"Lancet N Am Ed"},{"key":"10.1016\/j.ebiom.2022.104062_bib0017","doi-asserted-by":"crossref","first-page":"eabg3055","DOI":"10.1126\/science.abg3055","article-title":"Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England","volume":"372","author":"Davies","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2022.104062_bib0018","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.cell.2021.03.013","article-title":"Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity","volume":"184","author":"Garcia-Beltran","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2022.104062_bib0019","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.cell.2021.03.036","article-title":"SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies","volume":"184","author":"Hoffmann","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2022.104062_bib0020","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1056\/NEJMoa2102214","article-title":"Efficacy of the ChAdOx1 nCoV-19 COVID-19 vaccine against the B.1.351 variant","volume":"384","author":"Madhi","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2022.104062_bib0021","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-021-03398-2","article-title":"Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7","volume":"593","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2022.104062_bib0022","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41591-021-01285-x","article-title":"SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma","volume":"27","author":"Wibmer","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2022.104062_bib0023","volume":"21","author":"Puranik","year":"2021","journal-title":"Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence. medRxiv [Preprint]"},{"key":"10.1016\/j.ebiom.2022.104062_bib0024","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/s41591-021-01413-7","article-title":"Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals","volume":"27","author":"Kustin","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2022.104062_bib0025","article-title":"Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection in a large cohort","author":"Israel","year":"2021","journal-title":"Infect Dis"},{"key":"10.1016\/j.ebiom.2022.104062_bib0026","article-title":"Immunogenicity of BNT162b2 vaccine against the Alpha and Delta variants in immunocompromised patients","author":"Hadjadj","year":"2021","journal-title":"Infect Dis"},{"key":"10.1016\/j.ebiom.2022.104062_bib0027","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2022.104062_bib0028","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/nm.3985","article-title":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence","volume":"21","author":"Menachery","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2022.104062_bib0029","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1073\/pnas.1517719113","article-title":"SARS-like WIV1-CoV poised for human emergence","volume":"113","author":"Menachery","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2022.104062_bib0030","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/s41564-020-0771-4","article-title":"Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic","volume":"5","author":"Boni","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.ebiom.2022.104062_bib0031","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.372.6539.227","article-title":"The dream vaccine","volume":"372","author":"Cohen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2022.104062_bib0032","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.591535","article-title":"Emergence of bat-related betacoronaviruses: hazard and risks","volume":"12","author":"Frutos","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ebiom.2022.104062_bib0033","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3389\/fimmu.2019.01134","article-title":"DC subsets regulate humoral immune responses by supporting the differentiation of distinct Tfh Cells","volume":"10","author":"Bouteau","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2022.104062_bib0034","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1182\/blood-2012-01-402370","article-title":"Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cells","volume":"120","author":"Chatterjee","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2022.104062_bib0035","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1172\/JCI99005","article-title":"TLR3 agonist and CD40-targeting vaccination induces immune responses and reduces HIV-1 reservoirs","volume":"128","author":"Cheng","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ebiom.2022.104062_bib0036","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1097\/QAD.0b013e3283624305","article-title":"Targeting concatenated HIV antigens to human CD40 expands a broad repertoire of multifunctional CD4+ and CD8+ T cells","volume":"27","author":"Flamar","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.ebiom.2022.104062_bib0037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207794","article-title":"HIV-1 T cell epitopes targeted to rhesus macaque CD40 and DCIR: a comparative study of prototype dendritic cell targeting therapeutic vaccine candidates","volume":"13","author":"Flamar","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2022.104062_bib0038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009025","article-title":"TLR-9 agonist and CD40-targeting vaccination induces HIV-1 envelope-specific B cells with a diversified immunoglobulin repertoire in humanized mice","volume":"16","author":"Godot","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ebiom.2022.104062_bib0039","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ebiom.2016.01.029","article-title":"Functional Specialty of CD40 and dendritic cell surface lectins for exogenous antigen presentation to CD8+ and CD4+ T cells","volume":"5","author":"Yin","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ebiom.2022.104062_bib0040","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01596-16","article-title":"Superiority in rhesus macaques of targeting HIV-1 Env gp140 to CD40 versus LOX-1 in combination with replication-competent NYVAC-KC for induction of Env-specific antibody and T cell responses","volume":"91","author":"Zurawski","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2022.104062_bib0041","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-25382-0","article-title":"Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques","volume":"12","author":"Marlin","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2022.104062_bib0042","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.4049\/jimmunol.2000704","article-title":"Anti-CD40 antibodies fused to CD40 ligand have superagonist properties","volume":"207","author":"Ceglia","year":"2021","journal-title":"J Immunol"},{"key":"10.1016\/j.ebiom.2022.104062_bib0043","doi-asserted-by":"crossref","first-page":"e55595","DOI":"10.1371\/journal.pone.0055595","article-title":"ZnT8-specific CD4+ T cells display distinct cytokine expression profiles between type 1 diabetes patients and healthy adults","volume":"8","author":"Chujo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2022.104062_bib0044","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/cyto.a.21015","article-title":"SPICE: exploration and analysis of post-cytometric complex multivariate datasets","volume":"79A","author":"Roederer","year":"2011","journal-title":"Cytometry"},{"key":"10.1016\/j.ebiom.2022.104062_bib0045","series-title":"Flow Cytometry Protocols","first-page":"119","article-title":"Tracking immune cell proliferation and cytotoxic potential using flow cytometry","author":"Tario","year":"2011"},{"key":"10.1016\/j.ebiom.2022.104062_bib0046","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/bioinformatics\/btv639","article-title":"Gapped sequence alignment using artificial neural networks: application to the MHC class I system","volume":"32","author":"Andreatta","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ebiom.2022.104062_bib0047","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/imm.12889","article-title":"Improved methods for predicting peptide binding affinity to MHC class II molecules","volume":"154","author":"Jensen","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.ebiom.2022.104062_bib0048","doi-asserted-by":"crossref","first-page":"W24","DOI":"10.1093\/nar\/gkx346","article-title":"BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes","volume":"45","author":"Jespersen","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ebiom.2022.104062_bib0049","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.chom.2021.05.010","article-title":"SARS-CoV-2 human T cell epitopes: adaptive immune response against COVID-19","volume":"29","author":"Grifoni","year":"2021","journal-title":"Cell Host & Microbe"},{"key":"10.1016\/j.ebiom.2022.104062_bib0050","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41586-020-2169-0","article-title":"Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins","volume":"583","author":"Lam","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2022.104062_bib0051","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2022.104062_bib0052","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/s41467-021-21240-1","article-title":"Evidence for SARS-CoV-2 related coronaviruses circulating in bats and pangolins in Southeast Asia","volume":"12","author":"Wacharapluesadee","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2022.104062_bib0053","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2022.104062_bib0054","doi-asserted-by":"crossref","first-page":"6143","DOI":"10.1016\/j.vaccine.2017.09.052","article-title":"Human innate responses and adjuvant activity of TLR ligands in vivo in mice reconstituted with a human immune system","volume":"35","author":"Cheng","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2022.104062_bib0055","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1016\/j.vaccine.2016.08.071","article-title":"Targeting dendritic cells in humanized mice receiving adoptive T cells via monoclonal antibodies fused to Flu epitopes","volume":"34","author":"Graham","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2022.104062_bib0056","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1002\/jmv.26601","article-title":"Impact on disease mortality of clinical, biological, and virological characteristics at hospital admission and overtime in COVID-19 patients","volume":"93","author":"Yazdanpanah","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.ebiom.2022.104062_bib0057","doi-asserted-by":"crossref","first-page":"eabd2071","DOI":"10.1126\/sciimmunol.abd2071","article-title":"Phenotype and kinetics of SARS-CoV-2\u2013specific T cells in COVID-19 patients with acute respiratory distress syndrome","volume":"5","author":"Weiskopf","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.ebiom.2022.104062_bib0058","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.immuni.2021.04.006","article-title":"CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses","volume":"54","author":"Lineburg","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.ebiom.2022.104062_bib0059","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1016\/j.cell.2021.06.029","article-title":"Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses","volume":"184","author":"Nathan","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2022.104062_bib0060","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2022.104062_bib0061","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls","volume":"584","author":"Le Bert","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2022.104062_bib0062","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1371\/journal.pone.0000024","article-title":"Long-Term Persistence of Robust Antibody and Cytotoxic T Cell Responses in Recovered Patients Infected with SARS Coronavirus","volume":"1","author":"Li","year":"2006","journal-title":"PLoS One"},{"issue":"7898","key":"10.1016\/j.ebiom.2022.104062_bib0063","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41586-021-04387-1","article-title":"Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization","volume":"602","author":"Cele","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2022.104062_bib0064","article-title":"Considerable escape of SARS-CoV-2 Omicron to antibody neutralization","author":"Planas","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2022.104062_bib0065","article-title":"SARS-CoV-2 B.1.1.529 variant (Omicron) evades neutralization by sera from vaccinated and convalescent individuals","author":"R\u00f6ssler","year":"2021","journal-title":"Infect Dis"},{"key":"10.1016\/j.ebiom.2022.104062_bib0066","article-title":"Minimal cross-over between mutations associated with Omicron variant of SARS-CoV-2 and CD8+ T cell epitopes identified in COVID-19 convalescent individuals","author":"Redd","year":"2021","journal-title":"Immunology"},{"key":"10.1016\/j.ebiom.2022.104062_bib0067","article-title":"Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases","volume":"2","author":"Tarke","year":"2021","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.ebiom.2022.104062_bib0068","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(21)02249-2","article-title":"Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study","volume":"398","author":"Barda","year":"2021","journal-title":"Lancet N Am Ed"},{"key":"10.1016\/j.ebiom.2022.104062_bib0069","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108728","article-title":"Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients","volume":"34","author":"Tan","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.ebiom.2022.104062_bib0070","doi-asserted-by":"crossref","DOI":"10.1172\/JCI151969","article-title":"Cross-protective immunity following coronavirus vaccination and coronavirus infection","volume":"131","author":"Dangi","year":"2021","journal-title":"J Clin Invest"},{"issue":"7898","key":"10.1016\/j.ebiom.2022.104062_bib0071","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41586-021-04386-2","article-title":"Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift","volume":"602","author":"Cameroni","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2022.104062_bib0072","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/01621459.1963.10500845","article-title":"Hierarchical grouping to optimize an objective function","volume":"58","author":"Ward","year":"1963","journal-title":"J Am Stat Assoc"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422002432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422002432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:17:22Z","timestamp":1762456642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396422002432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":72,"alternative-id":["S2352396422002432"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104062","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.12.28.474244","asserted-by":"object"}]},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104062"}}